Pharming Group is engaged in the development of products for the treatment of unmet medical needs. The company focuses on the development and production of human therapeutic proteins to provide life-changing solutions to patients. Its product includes Ruconest. Most of the revenue generated from the United States.
| Website: | www.pharming.com |
| Email: | investor@pharming.com |
| Main Phone: | +31 715247400 |
| Address: | Darwinweg 24 |
| City / Town: | Leiden |
| Country: | NLD |
| Postal Code: | 2333 |
| Exchange: | OTO |
| Employees: | 150 |
| NAICS: | Biological Product (except Diagnostic) Manufacturing(325414) |
| Last Price 0.89 | Change $ -0.0441 | Change % -4.74 | Tick N/A |
| Bid N/A | Bid Size N/A | Ask N/A | Ask Size N/A |
| Open 0.94 | High 0.94 | Low 0.89 | Prev Close 0.93 |
| Last Trade | Volume 5,007 | 52 Wk Hi 1.96 | 52 Wk Low 0.83 |
| Market Cap 540.8 mi | Ex-Div Date N/A | Div Rate N/A | Yield N/A |
| Shares 610,411,062.00 | EPS (TTM) -0.11 | PE Ratio N/A | Exchange OTCPK |
| Current | 1 Week Ago | 2 Weeks Ago | 3 Weeks Ago | |
|---|---|---|---|---|
| High Target Price Estimate | 1.84 | 1.84 | 1.84 | 1.84 |
| Low Target Price Estimate | 1.84 | 1.84 | 1.84 | 1.84 |
| Mean Target Price Estimate | 1.84 | 1.84 | 1.84 | 1.84 |
| Standard Deviation | 0 | 0 | 0 | 0 |
| Date of Most Recent Estimate | 01/18/18 | 01/18/18 | 01/18/18 | 01/18/18 |
| Current | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 |
| Moderate Buy | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 |
| Moderate Sell | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 |
| Mean Rec. | 1 | 1 | 1 | 1 |
© 2018 Equities
* All dates and time are being displayed in Eastern Standard Time (EST).
